» Articles » PMID: 29922701

Phasing out of the Universal Mega Dose of Vitamin-A Prophylaxis to Avoid Toxicity

Overview
Specialty Public Health
Date 2018 Jun 21
PMID 29922701
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood blindness due to corneal ulceration was prevalent among poor Indian children. To tackle this situation, the National Institute of Nutrition (NIN), Hyderabad, India, Vitamin-A (Vit-A) prophylaxis programme was launched nationally in 1970 after field testing. Research of Indian Council for Medical Research (ICMR) documented that prevalence of Vit-A deficiency signs such as Bitot's spot decreased among children, over a period of time. However, this decrease cannot be ascertained is due to mass Vit-A prophylaxis programme. This is because coverage was low and patchy. Improved nutrition status, wider vaccination coverage, increased rate in breast feeding and improvement of healthcare services played a crucial role. Rather many studies revealed that (mass prophylaxis to the child who is having adequate Vit-A level) it may be harmful to certain group of children as a result of acute toxic symptoms. High dose of Vit-A is capable of loss of bone density-hence retarded growth may be observed in susceptible individuals. To tackle this issue food based approach should be promoted (which includes breast feeding) along with timely measles vaccination. The children who have signs of Vit-A deficiency (e.g. night blindness, xeropthalmia, Bitot's spot) or post measles children should receive Vit-A in age specific daily doses for two weeks along with Vit-A rich food, like green leafy vegetables, red palm oil, liver etc. Public spirited citizens, together with scientific community in India, should discourage this "one size fit to all" approach. It will not only avoid the ill effects of high dose of Vit-A but also it will help us optimal utilization of health resources in a resource poor country like India.

Citing Articles

Effects of primary or secondary prevention with vitamin A supplementation on clinically important outcomes: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Bjelakovic G, Nikolova D, Bjelakovic M, Pavlov C, Sethi N, Korang S BMJ Open. 2024; 14(5):e078053.

PMID: 38816049 PMC: 11141198. DOI: 10.1136/bmjopen-2023-078053.


Influences of Vitamin A on Vaccine Immunogenicity and Efficacy.

Penkert R, Rowe H, Surman S, Sealy R, Rosch J, Hurwitz J Front Immunol. 2019; 10:1576.

PMID: 31379816 PMC: 6651517. DOI: 10.3389/fimmu.2019.01576.

References
1.
Kapil U, Sachdev H . Massive dose vitamin A programme in India--need for a targeted approach. Indian J Med Res. 2013; 138(3):411-7. PMC: 3818610. View

2.
Vijayaraghavan K, Radhaiah G, Prakasam B, Sarma K, Reddy V . Effect of massive dose vitamin A on morbidity and mortality in Indian children. Lancet. 1990; 336(8727):1342-5. DOI: 10.1016/0140-6736(90)92895-o. View

3.
Ramakrishnan U, Latham M, Abel R, Frongillo Jr E . Vitamin A supplementation and morbidity among preschool children in south India. Am J Clin Nutr. 1995; 61(6):1295-303. DOI: 10.1093/ajcn/61.6.1295. View

4.
Sommer A . Vitamin a deficiency and clinical disease: an historical overview. J Nutr. 2008; 138(10):1835-9. DOI: 10.1093/jn/138.10.1835. View

5.
West Jr K, Pokhrel R, Katz J, LeClerq S, Khatry S, Shrestha S . Efficacy of vitamin A in reducing preschool child mortality in Nepal. Lancet. 1991; 338(8759):67-71. DOI: 10.1016/0140-6736(91)90070-6. View